Literature DB >> 25374908

Glomerular sparing pattern in primary kidney neoplasms: clinical, morphological and immunohistochemical study.

Faisal M Huq Ronny1, Judy Sarungbam1, Xuelin Zhong1, Yasmin Yusuf1, Ximing Yang2, Minghao Zhong1.   

Abstract

Glomerular sparing (GS) is defined as a unique growth pattern in which tumor cells replace the majority of renal tubes and overrun intact glomeruli. This phenomenon has been well recognized by pathologists as a typical infiltrative pattern and some studies suggested it was an independent risk factor. Here, we study the clinical, pathological, and immunohistochemical features of primary kidney neoplasms with glomerular sparing pattern. We searched the archives of our pathology department for nephrectomy specimens and reviewed all pathology reports from 2009-2013. We selected cases with tumor and collected clinicopathological information, focusing on re-evaluation of cases with glomerular sparing pattern. To facilitate our study we performed immunohistochemical stains of PAX-8, p63, and InI-1 on selected cases. We selected a total of 204 nephrectomy cases in this study, including 163 cases of renal cell carcinoma; 37 cases of urothelial carcinoma; 4 cases from other categories (Wilms tumor, primary diffuse large B-cell lymphoma, angiolipoma, rhabdoid tumor). Finally, we identified 7 cases of primary kidney tumors with glomerular sparing pattern: 2 cases of clear cell renal cell carcinomas (ccRCC), 1 case of collecting duct carcinoma, 2 cases of urothelial carcinoma (UC), 1 case of diffuse large B-cell lymphoma and 1 case of malignant rhabdoid tumor. The primary kidney tumors with glomerular sparing pattern are rare and incidence in our study is <4% (7/204). There is no specificity for any tumor type, but more commonly seen in high grade UC rather than RCC. It can also be seen in rare neoplasms such as collecting duct carcinoma, lymphoma and malignant rhabdoid tumor. These GS cases need to be recognized as they are often associated with high grade, high stage, large tumor size, and worse prognosis.

Entities:  

Keywords:  Glomerular sparing pattern; clinical; immunohistochemical study; morphological; primary kidney neoplasms

Year:  2014        PMID: 25374908      PMCID: PMC4219289     

Source DB:  PubMed          Journal:  Am J Clin Exp Urol        ISSN: 2330-1910


  17 in total

Review 1.  INI1-deficient tumors: diagnostic features and molecular genetics.

Authors:  Travis J Hollmann; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

2.  Sarcomatoid renal cell carcinoma with massive osteosarcomatous differentiation: an unusual image in clinical urology.

Authors:  Siamak Daneshmand; Shahin Chandrasoma; Christopher Lum
Journal:  Urology       Date:  2003-05       Impact factor: 2.649

3.  Sarcomatoid urothelial carcinoma of the renal pelvis.

Authors:  Anastasia M Canacci; Gregory T MacLennan
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

4.  TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.

Authors:  Isaac Kinde; Enrico Munari; Sheila F Faraj; Ralph H Hruban; Mark Schoenberg; Trinity Bivalacqua; Mohamad Allaf; Simeon Springer; Yuxuan Wang; Luis A Diaz; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; George J Netto
Journal:  Cancer Res       Date:  2013-10-11       Impact factor: 12.701

Review 5.  Immunohistochemical diagnosis of renal neoplasms.

Authors:  Luan D Truong; Steven S Shen
Journal:  Arch Pathol Lab Med       Date:  2011-01       Impact factor: 5.534

6.  N-terminal PAX8 polyclonal antibody shows cross-reactivity with N-terminal region of PAX5 and is responsible for reports of PAX8 positivity in malignant lymphomas.

Authors:  Lucas Moretti; L Jeffrey Medeiros; Kranthi Kunkalla; Michelle D Williams; Rajesh R Singh; Francisco Vega
Journal:  Mod Pathol       Date:  2011-10-28       Impact factor: 7.842

Review 7.  The challenging diagnosis of the rhabdoid carcinoma of the pelvis: a case report with literature review.

Authors:  Maria Rosaria Raspollini; Vincenzo Li Marzi; Giulio Nicita; Gregor Mikuz
Journal:  Appl Immunohistochem Mol Morphol       Date:  2012-03

8.  PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract.

Authors:  Roula Albadine; Luciana Schultz; Peter Illei; Dilek Ertoy; Jessica Hicks; Rajni Sharma; Jonathan I Epstein; George J Netto
Journal:  Am J Surg Pathol       Date:  2010-07       Impact factor: 6.394

9.  Growth pattern, an important pathologic prognostic parameter for clear cell renal cell carcinoma.

Authors:  Akitoshi Fukatsu; Toyonori Tsuzuki; Naoto Sassa; Toshinori Nishikimi; Tohoru Kimura; Tsuyoshi Majima; Yasushi Yoshino; Ryohei Hattori; Momokazu Gotoh
Journal:  Am J Clin Pathol       Date:  2013-10       Impact factor: 2.493

10.  Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma.

Authors:  Alex Chang; Fadi Brimo; Elizabeth A Montgomery; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2013-02-28       Impact factor: 3.466

View more
  1 in total

Review 1.  Vessel co-option in cancer.

Authors:  Elizabeth A Kuczynski; Peter B Vermeulen; Francesco Pezzella; Robert S Kerbel; Andrew R Reynolds
Journal:  Nat Rev Clin Oncol       Date:  2019-08       Impact factor: 66.675

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.